vs

Side-by-side financial comparison of Asana, Inc. (ASAN) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $201.0M, roughly 1.3× Asana, Inc.). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -34.0%, a 34.8% gap on every dollar of revenue. On growth, Asana, Inc. posted the faster year-over-year revenue change (9.3% vs -16.5%). Asana, Inc. produced more free cash flow last quarter ($15.5M vs $3.4M).

Asana, Inc. is an American software company based in San Francisco whose flagship Asana service is a web and mobile "work management" platform designed to help teams organize, track, and manage their work. Asana, Inc. was founded in 2008 by Dustin Moskovitz and Justin Rosenstein. The product launched commercially in April 2012. In September 2020, the company was valued at $5.5 billion following its direct listing.

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

ASAN vs HCM — Head-to-Head

Bigger by revenue
HCM
HCM
1.3× larger
HCM
$270.8M
$201.0M
ASAN
Growing faster (revenue YoY)
ASAN
ASAN
+25.9% gap
ASAN
9.3%
-16.5%
HCM
Higher net margin
HCM
HCM
34.8% more per $
HCM
0.7%
-34.0%
ASAN
More free cash flow
ASAN
ASAN
$12.1M more FCF
ASAN
$15.5M
$3.4M
HCM

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
ASAN
ASAN
HCM
HCM
Revenue
$201.0M
$270.8M
Net Profit
$-68.4M
$2.0M
Gross Margin
88.9%
37.7%
Operating Margin
-34.8%
-13.2%
Net Margin
-34.0%
0.7%
Revenue YoY
9.3%
-16.5%
Net Profit YoY
-19.4%
-83.6%
EPS (diluted)
$-0.29
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASAN
ASAN
HCM
HCM
Q4 25
$201.0M
$270.8M
Q3 25
$196.9M
Q2 25
$187.3M
$277.7M
Q1 25
$188.3M
$324.5M
Q4 24
$183.9M
Q3 24
$179.2M
Q2 24
$172.4M
$305.7M
Q1 24
$171.1M
Net Profit
ASAN
ASAN
HCM
HCM
Q4 25
$-68.4M
$2.0M
Q3 25
$-48.4M
Q2 25
$-40.0M
$455.0M
Q1 25
$-62.3M
$11.9M
Q4 24
$-57.3M
Q3 24
$-72.2M
Q2 24
$-63.7M
$25.8M
Q1 24
$-62.4M
Gross Margin
ASAN
ASAN
HCM
HCM
Q4 25
88.9%
37.7%
Q3 25
89.7%
Q2 25
89.7%
0.1%
Q1 25
89.6%
48.0%
Q4 24
89.2%
Q3 24
88.8%
Q2 24
89.7%
41.1%
Q1 24
89.8%
Operating Margin
ASAN
ASAN
HCM
HCM
Q4 25
-34.8%
-13.2%
Q3 25
-25.1%
Q2 25
-23.4%
-1.3%
Q1 25
-33.8%
-5.0%
Q4 24
-32.7%
Q3 24
-42.9%
Q2 24
-38.4%
-9.0%
Q1 24
-39.7%
Net Margin
ASAN
ASAN
HCM
HCM
Q4 25
-34.0%
0.7%
Q3 25
-24.6%
Q2 25
-21.4%
163.8%
Q1 25
-33.1%
3.7%
Q4 24
-31.2%
Q3 24
-40.3%
Q2 24
-37.0%
8.4%
Q1 24
-36.5%
EPS (diluted)
ASAN
ASAN
HCM
HCM
Q4 25
$-0.29
$0.00
Q3 25
$-0.20
Q2 25
$-0.17
$0.52
Q1 25
$-0.27
$0.01
Q4 24
$-0.25
Q3 24
$-0.31
Q2 24
$-0.28
$0.03
Q1 24
$-0.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASAN
ASAN
HCM
HCM
Cash + ST InvestmentsLiquidity on hand
$183.5M
$1.4B
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$188.4M
$1.2B
Total Assets
$840.4M
$1.8B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASAN
ASAN
HCM
HCM
Q4 25
$183.5M
$1.4B
Q3 25
$184.1M
Q2 25
$193.8M
$1.4B
Q1 25
$184.7M
$836.1M
Q4 24
$196.8M
Q3 24
$219.4M
Q2 24
$222.0M
$802.5M
Q1 24
$236.7M
Total Debt
ASAN
ASAN
HCM
HCM
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
ASAN
ASAN
HCM
HCM
Q4 25
$188.4M
$1.2B
Q3 25
$224.6M
Q2 25
$236.3M
$1.2B
Q1 25
$227.5M
$759.9M
Q4 24
$239.3M
Q3 24
$291.9M
Q2 24
$319.9M
$740.1M
Q1 24
$326.4M
Total Assets
ASAN
ASAN
HCM
HCM
Q4 25
$840.4M
$1.8B
Q3 25
$883.2M
Q2 25
$877.1M
$1.8B
Q1 25
$891.4M
$1.3B
Q4 24
$874.2M
Q3 24
$945.4M
Q2 24
$978.2M
$1.3B
Q1 24
$962.0M
Debt / Equity
ASAN
ASAN
HCM
HCM
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASAN
ASAN
HCM
HCM
Operating Cash FlowLast quarter
$16.2M
$8.2M
Free Cash FlowOCF − Capex
$15.5M
$3.4M
FCF MarginFCF / Revenue
7.7%
1.2%
Capex IntensityCapex / Revenue
0.3%
1.8%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$74.5M
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASAN
ASAN
HCM
HCM
Q4 25
$16.2M
$8.2M
Q3 25
$39.8M
Q2 25
$6.8M
$-72.9M
Q1 25
$15.9M
$40.3M
Q4 24
$-14.9M
Q3 24
$15.9M
Q2 24
$-1.9M
$-39.8M
Q1 24
$-15.3M
Free Cash Flow
ASAN
ASAN
HCM
HCM
Q4 25
$15.5M
$3.4M
Q3 25
$38.5M
Q2 25
$6.1M
$-82.2M
Q1 25
$14.3M
$32.5M
Q4 24
$-16.3M
Q3 24
$14.2M
Q2 24
$-2.9M
$-49.9M
Q1 24
$-15.8M
FCF Margin
ASAN
ASAN
HCM
HCM
Q4 25
7.7%
1.2%
Q3 25
19.6%
Q2 25
3.3%
-29.6%
Q1 25
7.6%
10.0%
Q4 24
-8.8%
Q3 24
7.9%
Q2 24
-1.7%
-16.3%
Q1 24
-9.3%
Capex Intensity
ASAN
ASAN
HCM
HCM
Q4 25
0.3%
1.8%
Q3 25
0.7%
Q2 25
0.3%
3.3%
Q1 25
0.8%
2.4%
Q4 24
0.7%
Q3 24
0.9%
Q2 24
0.6%
3.3%
Q1 24
0.3%
Cash Conversion
ASAN
ASAN
HCM
HCM
Q4 25
4.21×
Q3 25
Q2 25
-0.16×
Q1 25
3.38×
Q4 24
Q3 24
Q2 24
-1.54×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASAN
ASAN

US$118.5M59%
Non Us$82.5M41%

HCM
HCM

Segment breakdown not available.

Related Comparisons